Insulin Overdose: Dosage, Symptoms, And Treatment

Insulin overdose: Dosage, symptoms, and treatment

Insulin overdose: Dosage, symptoms, and treatment

Insulin is an important hormone used in medical treatments for people with type 1 and type 2 diabetes. It helps the body's cells to properly absorb sugar.
Insulin is a lifesaving medication when taken correctly, but an insulin overdose can have some serious side effects.
This article explores signs of insulin overdose to look out for, as well as steps to take to avoid insulin overdoses.
Contents of this article:
Safe vs. unsafe insulin doses
There are a few things to consider to ensure a correct insulin dose. Insulin doses can vary greatly from person to person. The normal dose for one person may be considered an overdose for another.
Basal insulin
The insulin needed to keep the blood sugar steady throughout the day is called basal insulin.
The amount of insulin needed changes from person to person based on what time of day they take it, and whether their body is resistant to insulin or not. It is best to consult a doctor to figure out the appropriate basal insulin dosage.
Mealtime insulin
Mealtime insulin is insulin that is taken after a meal. Glucose (sugar) is released into the bloodstream as the body breaks down food, which raises the blood sugar levels.
In people with diabetes, this extra sugar must be met with extra insulin so the body can use it properly.
There are a few different factors to be considered in terms of the mealtime insulin levels. People with diabetes have to consider:
their pre-meal blood sugar
how many carbs are in the food they are eating
if they plan to do anything active after the meal
Then they must factor in their own level of insulin sensitivit Continue reading

Rate this article
Total 1 ratings
Insulin price spike leaves diabetes patients in crisis

Insulin price spike leaves diabetes patients in crisis

A massive spike in insulin prices is causing a health crisis for millions of diabetes patients who depend on the lifesaving drug, doctors say.
Now, after years of rapid increases having nothing to do with available supply and not matched elsewhere in the world, those in the U.S. insulin supply chain are blaming one another.
Tens of thousands of medical professionals are engaged in an intricate therapeutic ballet performed to protect the health, limbs and lives of the almost 30 million people in the U.S. suffering from diabetes.
But their efforts have been dramatically complicated by the soaring increase in the cost of insulin. They find themselves balancing the cost of the essential medication and their patients’ ability to pay.
“The manipulation of insulin cost is a medical crisis in Montana and everywhere else in this country,” said Dr. Justen Rudolph, a diabetes specialist at St. Vincent Healthcare in Billings. “My patients having trouble with their insulin availability range from teenagers to a 90-year-old man, and there’s not a day that goes by when I’m not talking to a patient about the cost of their insulin.
“They try to spread out the insulin they have to make do, and that’s not how you can control diabetes,” said Rudolph.
“Precision is needed to ensure the patient is getting the best type of insulin for their specific condition, in the right doses, at the right time to achieve the greatest benefit,” said Dr. Irl Hirsch, professor of medicine in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington in Seattle.
Continue reading

Screentime linked to greater diabetes risk among children

Screentime linked to greater diabetes risk among children

Children who are allowed more than three hours of screentime a day are at greater risk of developing diabetes, new research suggests.
The study found that children who were glued to their screens for three or more hours a day scored higher on measures of body fat and had higher levels of resistance to the hormone insulin than their peers who spent an hour or less watching TV, videos or playing computer games.
But the authors cautioned that the research does not show that increased screentime itself results in raised levels of risk factors for the disease.
“Screentime could be capturing something about your behaviours – how much sedentary time you have and how much you break that up [or] what your dietary habits [are], potentially,” said Claire Nightingale, a medical statistician at St George’s, University of London and co-author of the research.
Writing in the journal Archives of Disease in Childhood, Nightingale and colleagues described how they sought to probe whether for children, as is known for adults, screentime is linked to an increase in risk factors for type 2 diabetes. To do so, they analysed data from the Child Heart and Health Study in England – a survey carried out between 2004 and 2007 of almost 4,500 children, aged between nine and 10, from primary schools in three UK cities: London, Birmingham and Leicester.
Among the questions asked, data was collected on the length of time the children spent watching TV, video games or playing computer games. A host of physical measurements were also taken including measures of the children’s body fat and resis Continue reading

Are you diabetic or could you be pre diabetic – World Diabetes Day 2017

Are you diabetic or could you be pre diabetic – World Diabetes Day 2017

Women are the gatekeepers of household nutrition and lifestyle habits. They have the potential to drive prevention in their household and beyond. – International Diabetes Federation
Diabetes is the fastest growing health issue in Australia today.
1.2 million Australians have been diagnosed.
500,000 are estimated to be undiagnosed type 2 diabetics.
And every 5 minutes another Australian develops type 2 diabetes.
But the truly alarming fact is the number of people who are estimated to be pre–diabetic.
Diabetes Australia believes the pre-diabetic figure to be around 2,000,000 people with some medical institutions around the country reporting levels as high as 30-40% of the local population. These people are at high risk of developing diabetes type 2 if they do not take action.
What Causes Diabetes
When food is digested and enters your bloodstream, insulin moves glucose out of the blood and into cells, where it is broken down to produce energy.
However, if you have diabetes, your body cannot break down glucose into energy. This is because there is either not enough insulin to move the glucose, or the insulin produced does not work properly. Glucose builds up in the blood resulting in high blood glucose levels.
Diabetes types
There are 3 main types of diabetes
Diabetes type 1
Type 1 diabetes is an auto-immune disease where the body’s immune system attacks the insulin-producing cells of the pancreas. People with type 1 diabetes cannot produce insulin and require lifelong insulin replacement for survival.
The disease can occur at any age, although it mostly occurs in childre Continue reading

Invokana Linked To Increased Risk Of Leg, Foot & Toe Amputations

Invokana Linked To Increased Risk Of Leg, Foot & Toe Amputations

Current Invokana patients should watch for pain and tenderness in the feet, legs or toes, while physicians are instructed to screen prospective patients for factors that increase the risk of amputation.
Invokana Amputation Lawsuits
Hundreds of type 2 diabetes patients have already filed Invokana lawsuits against Janssen Pharmaceutical, the drug’s manufacturer and a subsidiary of global giant Johnson & Johnson. Today, more than 850 lawsuits are consolidated in the US District Court of New Jersey, claiming Invokana causes multiple severe complications, including diabetic ketoacidosis and kidney failure. With new medical evidence confirming a link between Invokana and amputations, legal observers believe that hundreds of other type 2 diabetes patients may also be able to file suit.
Increased Risk For Foot & Leg Amputations
New statistical analyses confirm that patients taking Invokana, Invokamet or Invokamet XR are around twice as likely to require leg and foot amputations than patients taking a placebo.
Alarmed by these recent findings, experts at the US Food & Drug Administration have now formally warned patients of Invokana’s newly-identified risk. On May 16, 2017, the FDA issued an urgent safety announcement, citing new data from two major clinical trials that investigated the drug’s potential dangers for eight years.
The risk for limb amputations, however, only became conclusive once these trials, known in medical circles as CANVAS and CANVAS-R, were completed in July 2017.
Want to share this infographic on your site? Use the code below, but please Continue reading

No more pages to load

Popular Articles

  • #51: Diabetes treatment in 2017: New meds, insulin, and cardiac risk reduction

    Get cozy with these new drugs for diabetes treatment. Don’t be scared, they won’t bite. On this episode, we interview Endocrinologist and current president of AACE, Dr. Jonathan D. Leffert, MD, FACP, FACE, ECNU about how to utilize the myriad of new diabetes drugs on the marketplace including SGLT2 inhibitors, DPP4 inhibitors, GLP1 agonists, and new ultra long acting insulins. Plus, we’ll te ...

  • UAlberta research may provide solutions for the future treatment of diabetes and insulin resistance

    We are the Faculty of Medicine & Dentistry at the University of Alberta, one of the worlds elite academic health sciences centres, where top students are taught by award-winning educators and mentored by renowned scientists in a dynamic learning environment. We conduct our teaching, research and patient care in accordance with the highest international standards. We work with our partners in ed ...

  • Diabetes in Children and Teens: Signs and Symptoms

    With more than a third of diabetes cases in the United States occurring in people over the age of 65, diabetes is often referred to as an age-related condition. But around 208,000 children and adolescents are estimated to have diabetes, and this number is increasing. Type 1 diabetes is the most common form of the condition among children and adolescents. A 2009 report from the Centers for Disease ...

  • Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations With Mortality Risk

    OBJECTIVE Depression is strongly linked to increased mortality in individuals with type 2 diabetes. Despite high rates of co-occurring anxiety and depression, the risk of death associated with comorbid anxiety in individuals with type 2 diabetes is poorly understood. This study documented the excess mortality risk associated with symptoms of depression and/or anxiety comorbid with type 2 diabetes. ...

  • New diabetes treatment could eliminate need for insulin injections

    A cell-based diabetes treatment has been developed by scientists who say it could eliminate the need for those with the condition to inject insulin. The therapy involves a capsule of genetically engineered cells implanted under the skin that automatically release insulin as required. Diabetic mice that were treated with the cells were found to have normal blood sugar levels for several weeks. Scie ...

  • Diabetes treatment: THIS new drug could be biggest development since discovery of insulin

    Researchers have discovered that a drug commonly used to treat type 2 diabetes patients could also benefit those with type 1 diabetes. A study by the University of Buffalo has revealed that type 1 patients given dapagliflozin - a medication traditionally given to type 2 sufferers - experienced a significant decline in their blood sugar levels. Until now, there hadn’t been a significant developme ...

  • Mastery in Diabetes Management: Doxycycline Treatment for Insulin Resistance

    Erjola Balliu, MD Erjola Balliu, MD, of Stony Brook Hospital in New York, spoke with MedPage Today at ENDO 2017, the annual meeting of The Endocrine Society, where she reported finding that use of the antibiotic doxycycline was associated with improved fasting glucose when compared to placebo in a proof-of-concept study. Her full poster may be downloaded by clicking here. Following is a transcript ...

  • Type 1 diabetes treatment could end need for insulin shots

    Insulin shots could become a thing of the past for type 1 diabetes patients thanks to a technology being developed by Cell and Gene Therapy Catapult, a London-based not-for-profit organisation, and Aberdeen University. The pre-clinical results have encouraged CGT and Aberdeen University to create a spin-out company, called Islexa. It will manufacture lab-grown islets, the organoids responsible for ...

  • Are synthetic insulin-secreting cells the future of diabetes treatment?

    2 pictures While treatments for type 1 diabetes are rapidly evolving, even the most recent hi-tech artificial pancreas system still involves glucose monitors and insulin pumps. But a new development from scientists at the University of North Carolina and NC State could do away with the need for injections and glucose monitoring through the use of artificial beta cells that mimic the insulin-secret ...

Related Articles